'Flawed' Taiwan Study Causes Drop in Shares of Exact Sciences (EXAS)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Exact Sciences (EXAS) Selloff 'Overblown' Says Canaccord, 'We Would Aggressively Buy'
January 17, 2018 12:24 PM ESTCanaccord Genuity maintains Buy on Exact Sciences (NASDAQ: EXAS) price target of $60.00
For an analyst ratings summary and ratings history on Exact Sciences click here. For more ratings news on Exact Sciences click here.
Shares of Exact Sciences closed at $52.95 yesterday.
... MoreExact Sciences (EXAS) Sell-Off 'Overdone' - Cowen
January 17, 2018 12:15 PM ESTCowen analyst Doug Schenkel defended at Exact Sciences (NASDAQ: EXAS) following an abstract detailing performance of a blood-based colorectal cancer screening test.
Schenkel said while the data looks interesting "this is a relatively small, single-site study that includes a disproportionate amount of... More
Exact Sciences (EXAS) option implied volatility increases as shares sell off after release of abstract
January 17, 2018 12:03 PM ESTExact Sciences (NASDAQ: EXAS) January call option implied volatility is at 108, February is at 61; compared to its 52-week range of 39 to 69 after release of abstract.
... MoreExact Sciences (EXAS) Defended at William Blair
January 17, 2018 12:02 PM ESTWilliam Blair maintains Outperform on Exact Sciences (NASDAQ: EXAS).
For an analyst ratings summary and ratings history on Exact Sciences click here. For more ratings news on Exact Sciences click here.
Shares of Exact Sciences closed at $52.95 yesterday.
... MoreExact Sciences (EXAS) Defended at Baird, 'selloff overdone'
January 17, 2018 11:16 AM ESTBaird maintains Neutral on Exact Sciences (NASDAQ: EXAS) price target of $56.00
For an analyst ratings summary and ratings history on Exact Sciences click here. For more ratings news on Exact Sciences click here.
Shares of Exact Sciences closed at $52.95 yesterday.
... MoreUPDATE: Exact Sciences (EXAS) Slips to Session Low
January 17, 2018 10:01 AM EST(Updated - January 17, 2018 10:06 AM EST)
Exact Sciences (NASDAQ: EXAS) declined to session Wednesday morning. Traders tied the fall to a news release that said a new study has found that a test that identifies circulating tumor cells (CTCs) present in the... More
Exact Sciences (EXAS) Weaker as Competing Test Shows Promise
January 17, 2018 9:59 AM ESTExact Sciences (NASDAQ: EXAS) sees weakness amid news Liquid Biopsy Test Shows Promise for Detecting Early-Stage Colorectal Cancer (LINK)
... More